awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38662393-29168C08-BD5F-46BD-BCCA-2D3248522CE7
Q38662393-29168C08-BD5F-46BD-BCCA-2D3248522CE7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38662393-29168C08-BD5F-46BD-BCCA-2D3248522CE7
Dose-related efficacy and toxicity of gemtuzumab ozogamicin in pediatric acute myeloid leukemia.
P2860
Q38662393-29168C08-BD5F-46BD-BCCA-2D3248522CE7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38662393-29168C08-BD5F-46BD-BCCA-2D3248522CE7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
26d35dae1413f5944fe2e9e796a02204ae7832ab
P2860
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia.